MARKET

PLSE

PLSE

Pulse Biosciences Inc
NASDAQ
6.86
+0.01
+0.15%
Closed 18:16 04/24 EDT
OPEN
6.92
PREV CLOSE
6.86
HIGH
6.94
LOW
6.67
VOLUME
129.16K
TURNOVER
0
52 WEEK HIGH
13.62
52 WEEK LOW
3.780
MARKET CAP
378.85M
P/E (TTM)
-7.8070
1D
5D
1M
3M
1Y
5Y
Pulse Biosciences Inc: [Amend]Registration statement under Securities Act of 1933
Press release · 1d ago
Weekly Report: what happened at PLSE last week (0415-0419)?
Weekly Report · 3d ago
Weekly Report: what happened at PLSE last week (0408-0412)?
Weekly Report · 04/15 10:25
Weekly Report: what happened at PLSE last week (0401-0405)?
Weekly Report · 04/08 10:28
Pulse Biosciences to sell subscription rights to purchase up to 6M units
Healthcare Pulse Biosciences to sell subscription rights to purchase up to 6M units for value of up to $60M. ETPulse Bioscience, Inc. (PLSE) files prospectus to sell subscriptions rights to buy up to six million units.
Seeking Alpha · 04/04 14:00
Health Care Sector Update for 04/01/2024: AEON, PLSE, GILD, XLO, EIGR
NASDAQ · 04/01 19:56
Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Nuvve Holding Corp. (NASDAQ:NVVE) fell sharply after the company reported worse-than-expected fourth-quarter financial results. The company posted a quarterly loss of $6.98 per share. Vast Renewables Limited shares jumped 179% to $8.62 after jumping 39% on Thursday.
Benzinga · 04/01 18:31
Precision Biosciences, Mesoblast, Pulse Biosciences among healthcare movers
Precision Biosciences, Mesoblast, Pulse Bioscience among healthcare movers. S&P 500 Health Care Sector -0.89% to 1708.7. Pharmaceuticals, Biotechnology & Life Science contributes 58% to index. Health Care Select Sector SPDR® Fund ETF.
Seeking Alpha · 04/01 14:00
More
About PLSE
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. The Company’s Nano-pulse Stimulation (NPS) technology is an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. The Company has designed a variety of applicators, or end-effectors, to explore the potential use of the CellFX platform to treat disorders in other medical specialties, such as cardiology, gastroenterology, gynecology, and ear, nose, and throat.

Webull offers Pulse Biosciences Inc stock information, including NASDAQ: PLSE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLSE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLSE stock methods without spending real money on the virtual paper trading platform.